Press Releases | OnKure, Inc.

March 4, 2021

OnKure, Inc. Raises $55 Million Series B Financing

September 21, 2020

OnKure and Pfizer Enter Clinical Trial Collaboration and Supply Agreement to Evaluate Combination of OKI-179 and Binimetinib

September 24, 2019

OnKure Expands Executive Team and Appoints Head of Discovery, Chief Financial Officer and General Counsel

July 23, 2019

OnKure Executes License and Option Agreement with KDAc Therapeutics

June 11, 2019

OnKure and CU Cancer Center announce first patient enrolled in clinical trial of OKI-179

May 06, 2019

OnKure Announces FDA IND Regulatory Clearance to Start Phase 1 Trials for OKI-179

May 02, 2018

OnKure Close $7M Series A Financing to Support Development of Epigenetics Drug